SCHEMBL12228367

SCHEMBL12228367

COc1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(Br)cc3)n2)c(O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.54
PTPN1 P18031 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
TP53 P04637 4/20 0.50
NFKB1 P19838 3/20 0.50
NFKB2 Q00653 3/20 0.50
RELA Q04206 3/20 0.50
RAB9A P51151 5/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPT P10636 3/20 0.49
NCOA1 Q15788 1/20 0.48
NCOA3 Q9Y6Q9 1/20 0.48
BACE1 P56817 1/20 0.48
IDH1 O75874 1/20 0.47
TDP1 Q9NUW8 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HTT P42858 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL195208 0.92 NPC1 (0.59) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL15910010 0.92 NPC1 (0.59) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL807727 0.92 NPC1 (0.59) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL29353657 0.92 NPC1 (0.62) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL39669 0.92 NPC1 (0.62) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL17920176 0.92 NPC1 (0.62) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL17571546 0.87 TSHR (0.59) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL13938599 0.86 NPC1 (0.61) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL12997145 0.86 NPC1 (0.54) NPC1PTPN1SMN1; SMN2TP53NFKB1
SCHEMBL12997352 0.86 NPC1 (0.54) NPC1PTPN1SMN1; SMN2TP53NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044123-B2 Ultraviolet absorber composition and resin composition FUJIFILM CORPORATION (JP) 2011-10-25 US disclosed
US-8044123-B2 Ultraviolet absorber composition and resin composition FUJIFILM CORPORATION (JP) 2011-10-25 US disclosed
US-20110077330-A1 POLYCARBONATE RESIN COMPOSITION CONTAINING TRIAZINE COMPOUND AND MOLDED ARTICLE USING THE SAME FUJIFILM CORPORATION (JP) 2011-03-31 US disclosed
US-20100324181-A1 ULTRAVIOLET ABSORBER COMPOSITION AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-23 US disclosed
US-20100324181-A1 ULTRAVIOLET ABSORBER COMPOSITION AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-23 US disclosed
US-20100311877-A1 NOVEL TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-09 US disclosed
US-20100311877-A1 NOVEL TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311877-A1 NOVEL TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION AVPR1B, H1-0, H1-2 NPC1 3106/4885PTPN1 4614/4885SMN1; SMN2 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.